Antidepressants play a complex role in Alzheimer's disease and dementia treatment, often addressing symptoms beyond depression. In Alzheimer's, they can alleviate behavioral symptoms like agitation and irritability. Selective serotonin reuptake inhibitors (SSRIs) such as sertraline are commonly prescribed due to their tolerability and safety profile in older adults. SSRIs may also enhance serotonin levels, potentially benefiting mood and cognition.
However, caution is crucial due to possible side effects such as drowsiness or interactions with other medications. Finding the right antidepressant and dosage requires individualized care. Moreover, treating depression in dementia patients can improve their quality of life and may modestly slow cognitive decline. Still, more research is needed to fully understand the long-term effects and optimal use of antidepressants in managing Alzheimer's and dementia.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States